Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 15 Nasopharyngeal Carcinoma 8 Lung Neoplasms 7 Uterine Cervical Neoplasms 3 Melanoma 3 Esophageal Squamous Cell Carcinoma 3 Colorectal Neoplasms 3 Nasopharyngeal Neoplasms 2 Lymphoma, T-Cell 2 Breast Neoplasms 2 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Radiation Injuries 1 Quality of Life 1 Osteosarcoma 1 Non-squamous Non-small Cell Lung Cancer 1 Neuroblastoma 1 Lymphoma, T-Cell, Peripheral 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Esophageal 1 Carcinoma, Hepatocellular 1 Bone Neoplasms 1 Advanced Pancreatic Cancer 1 Advanced Gastric Cancer 1 Advanced Colorectal Cancer 1

Interventions

Oxaliplatin 3 regorafenib 2 Irinotecan 2 Drug Therapy 2 Cetuximab 2 Capecitabine 2 trifluridine tipiracil drug combination 1 surufatinib 1 raltitrexed 1 paclitaxel poliglumex 1 nimotuzumab 1 endostar protein 1 durvalumab 1 defactinib 1 aflibercept 1 Panitumumab 1 Fluorouracil 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Colorectal Cancer × endostar protein × Clear all

NCT00853684 2009-09-18

OXCE

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown

Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡